Amsterdam has the right mix

The Netherlands has officially announced Amsterdam’s candidacy for hosting the European Medicines Agency (EMA). The Dutch government argued that Amsterdam is the most suitable location and that the Netherlands offers all the facilities necessary for the agency to relocate quickly and efficiently.

“It is my pleasure to inform you of the Netherlands' candidacy to host the European Medicines Agency in Amsterdam,” Dutch Prime Minister Mark Rutte wrote in a letter to EU president Donald Tusk.

Amsterdam has “outstanding international travel connections and excellent working and living conditions,” Rutte wrote, adding that it “meets all the requirements of the agency and its staff.” In addition, the Netherlands’ own Medicines Evaluation Board is one of the most prominent national medicine regulators in Europe, Dutch government officials said.


As a result of Brexit, the European Commission wants to find a new seat for EU agencies based in the UK, such as the EMA, and they wish to do so as soon as possible. Other EU states that have expressed interest in hosting the agency include Sweden, Denmark, Italy, France, Ireland, Germany, Greece, Croatia and Spain.

The EMA, launched in 1995, is an EU agency that is responsible for the evaluation and monitoring of medicines developed by pharmaceutical companies for use in the EU. The agency has a workforce of about 900 highly skilled employees from all over Europe, including many pharmacists, biologists and doctors. The agency also hosts thousands of meetings each year, which partially explains why it has received the attention of so many EU member states.